Evidence map›Paper›PMID 24128932›Full record

ArticleAutophagy2013

MitoTimer: a novel tool for monitoring mitochondrial turnover.

Genaro Hernandez, Christine Thornton, Aleksandr Stotland, Diana Lui, Jon Sin, Jennifer Ramil, Najib Magee, Allen Andres, Giovanni Quarato, Raquel S Carreira and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 1 synthesis or guideline pooled it, 180 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. A fixed mutation in the respiratory complex I impairs mitochondrial bioenergetics in the endangered Apennine brown bear.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Genaro HernandezSan Diego State University; San Diego, CA USA.
Christine Thornton
Aleksandr Stotland
Diana Lui
Jon Sin
Jennifer Ramil
Najib Magee
Allen Andres
Giovanni Quarato
Raquel S Carreira
M Richard Sayen
Roland Wolkowicz
Roberta A Gottlieb
San Diego State University · USUniversity of California, San Diego · US

Funding

Protein Chemistry and ProteomicsP01HL112730 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI VAN EYK, JENNIFER E · 2013 to 2017
$12.0M
THE INTERSECTION OF LANGUAGE AND AFFECTR25GM058906 · NIGMS · SAN DIEGO STATE UNIVERSITY · PI TONG, WILLIAM G. · 1999 to 2021
$10.7M
Rescue and Role of Complex I in myocardial ischemic injuryR01HL060590 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI GOTTLIEB, ROBERTA A. · 1998 to 2011
$3.6M
Subcellular Regulation of Autophagic Flux in Cardiomyocytes and the HeartR01AG033283 · NIA · SAN DIEGO STATE UNIVERSITY · PI GOTTLIEB, ROBERTA A. · 2008 to 2012
$1.5M
NHLBI NIH HHS 5R01HL060590-15NHLBI NIH HHS P01 HL112730NHLBI NIH HHS R01 HL060590NIA NIH HHS 5R01AG033283-05NIA NIH HHS R01 AG033283NIGMS NIH HHS 2R25GM058906-09A2NIGMS NIH HHS R25 GM058906
6 · The paper itself

Abstract

Fluorescent Timer, or DsRed1-E5, is a mutant of the red fluorescent protein, dsRed, in which fluorescence shifts over time from green to red as the protein matures. This molecular clock gives temporal and spatial information on protein turnover. To visualize mitochondrial turnover, we targeted Timer to the mitochondrial matrix with a mitochondrial-targeting sequence (coined "MitoTimer") and cloned it into a tetracycline-inducible promoter construct to regulate its expression. Here we report characterization of this novel fluorescent reporter for mitochondrial dynamics. Tet-On HEK 293 cells were transfected with pTRE-tight-MitoTimer and production was induced with doxycycline (Dox). Mitochondrial distribution was demonstrated by fluorescence microscopy and verified by subcellular fractionation and western blot analysis. Dox addition for as little as 1 h was sufficient to induce MitoTimer expression within 4 h, with persistence in the mitochondrial fraction for up to 6 d. The color-specific conformation of MitoTimer was stable after fixation with 4% paraformaldehyde. Ratiometric analysis of MitoTimer revealed a time-dependent transition from green to red over 48 h and was amenable to analysis by fluorescence microscopy and flow cytometry of whole cells or isolated mitochondria. A second Dox administration 48 h after the initial induction resulted in a second round of expression of green MitoTimer. The extent of new protein incorporation during a second pulse was increased by administration of a mitochondrial uncoupler or simvastatin, both of which trigger mitophagy and biogenesis. MitoTimer is a novel fluorescent reporter protein that can reveal new insights into mitochondrial dynamics within cells. Coupled with organelle flow cytometry, it offers new opportunities to investigate mitochondrial subpopulations by biochemical or proteomic methods.

Indexed as

Mitochondrial TurnoverAnimalsFlow CytometryHEK293 CellsHumansLuminescent ProteinsMiceMitochondriaMitochondrial ProteinsMutant ProteinsProtein TransportRecombinant Fusion ProteinsRed Fluorescent ProteinTime FactorsLuminescent ProteinsMitochondrial ProteinsMitoTimer proteinMutant ProteinsRecombinant Fusion ProteinsRed Fluorescent Proteinfluorescence imagingFluorescent Timer proteinmitochondriamitochondrial turnovermitophagy

Identifiers

PMID24128932
PMCPMC4028337
OpenAlexW2092626982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.